In this episode, Suzanne Spradley and Chase Cannon review the outlook of health policy in the current Washington, DC environment. Suzanne leads off, setting the stage with a description of the narrow House Republican majority and its impact on enacting legislation. Suzanne and Chase discuss several pieces of legislation focused on transparency, including site-neutral payment reform and drug pricing. The two address regulatory activity that potentially targets PBMs and No Surprises Act issues. The episode concludes with a discussion of legislative and regulatory impact on employer group health plans.